Senores Pharmaceuticals (SENORES) Shareholding Pattern

NSE: SENORES • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 45.80%
FII Holding 3.35%
DII Holding 9.31%
Public Holding 31.94%
Total Shareholders 34,401
As of Dec 2025
View the latest shareholding pattern of Senores Pharmaceuticals (SENORES) including promoter, FII, DII, and public holdings. Track SENORES ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See SENORES P/E comparison)

Senores Pharmaceuticals (SENORES) Shareholding Summary

  • Promoter holding remains unchanged at 45.80% in Dec 2025
  • FII/FPI have decreased holdings from 4.28% to 3.35% in Dec 2025
  • DIIs have increased holdings from 8.61% to 9.31% in Dec 2025
  • Institutional investors have decreased holdings from 12.89% to 12.66% in Dec 2025
  • Public holding has increased from 31.09% to 31.94% in Dec 2025
  • Number of shareholders decreased from 34,917 to 34,401 in Dec 2025

SENORES Quarterly Ownership Changes

Quarter-over-quarter changes for Senores Pharmaceuticals from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
-0.93%
DII Holding Change
Sept 2025 to Dec 2025
+0.7%
Public Holding Change
Sept 2025 to Dec 2025
+0.85%

Senores Pharmaceuticals (SENORES) Quarterly Shareholding Trends

Visual breakdown of SENORES ownership distribution over time. Learn more about SENORES quarterly financials.

Promoter
FII
DII
Public
Government

Rising institutional holdings in SENORES often correlate with improved fundamentals. Check out SENORES share price history.

Senores Pharmaceuticals (SENORES) Shareholding Data

Download complete SENORES ownership data for offline analysis. Discover SENORES Q4 results.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 45.80% 3.35% 9.31% 0.00% 31.94% 9.59% 99.99% 34,401
Sept 2025 45.80% 4.28% 8.61% 0.00% 31.09% 10.22% 100.00% 34,917
Jun 2025 45.78% 3.67% 9.51% 0.00% 31.44% 9.60% 100.00% 36,389
Mar 2025 45.77% 4.17% 9.65% 0.00% 31.43% 8.97% 99.99% 37,653
Dec 2024 45.76% 4.25% 11.78% 0.00% 28.71% 9.49% 99.99% 43,707
Sept 2024 45.76% 5.51% 18.61% 0.00% 27.88% 2.23% 99.99% 43,707
Jul 2024 66.66% 0.00% 0.00% 0.00% 0.00% 33.34% 100.00% 177

SENORES promoter holding above 50% indicates strong insider confidence. Explore the SENORES fair price for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 45.80% 3.35% 9.31% 0.00% 31.94% 9.59% 99.99% 34,401
Sept 2025 45.80% 4.28% 8.61% 0.00% 31.09% 10.22% 100.00% 34,917
Jun 2025 45.78% 3.67% 9.51% 0.00% 31.44% 9.60% 100.00% 36,389
Mar 2025 45.77% 4.17% 9.65% 0.00% 31.43% 8.97% 99.99% 37,653
Dec 2024 45.76% 4.25% 11.78% 0.00% 28.71% 9.49% 99.99% 43,707
Sept 2024 45.76% 5.51% 18.61% 0.00% 27.88% 2.23% 99.99% 43,707
Jul 2024 66.66% 0.00% 0.00% 0.00% 0.00% 33.34% 100.00% 177

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 45.80% 3.35% 9.31% 0.00% 31.94% 9.59% 99.99% 34,401
Dec 2024 45.76% 4.25% 11.78% 0.00% 28.71% 9.49% 99.99% 43,707

Year-over-year trends reveal long-term ownership shifts.

Understanding Senores Pharmaceuticals (SENORES) Shareholding Pattern

Senores Pharmaceuticals shareholding pattern reveals who owns SENORES stock and how ownership changes over time. High promoter stakes in SENORES often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your SENORES trades. Senores Pharmaceuticals intrinsic worth

Combine SENORES ownership analysis with price movements and financial performance for a complete investment picture. (See SENORES P/B ratio history)